Skip to main content
Livermore
Livermore
ZHEN

HM Payson & Co

SEC CIK
0000928052
Latest filing
Jul 17, 2026

ABT holding history

Abbott Laboratories in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
354,529
Value
$32.2M
% of portfolio
0.4%
Quarters held
22
Since Q1 2021
Holdings of ABT by HM Payson & Co, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026354,529$32.2M0.4%−15,789−4.3%ReducedHolders
Q1 2026370,318$38.0M0.5%−6,800−1.8%ReducedHolders
Q4 2025377,118$47.2M0.7%−6,572−1.7%ReducedHolders
Q3 2025383,690$51.4M0.7%−1,722−0.4%ReducedHolders
Q2 2025385,412$52.4M0.8%−6,024−1.5%ReducedHolders
Q1 2025391,436$51.9M0.9%−1,124−0.3%ReducedHolders
Q4 2024392,560$44.4M0.8%−7,447−1.9%ReducedHolders
Q3 2024400,007$45.6M0.8%−6,717−1.7%ReducedHolders
Q2 2024406,724$42.3M0.8%−10,833−2.6%ReducedHolders
Q1 2024417,557$47.5M0.9%+2,657+0.6%AddedHolders
Q4 2023414,900$45.7M0.9%−6,529−1.5%ReducedHolders
Q3 2023421,429$40.8M1.0%−2,364−0.6%ReducedHolders
Q2 2023423,793$46.2M1.0%−15,506−3.5%ReducedHolders
Q1 2023439,299$44.5M1.1%−475−0.1%ReducedHolders
Q4 2022439,774$48.3M1.2%−6,502−1.5%ReducedHolders
Q3 2022446,276$43.2M1.2%−6,724−1.5%ReducedHolders
Q2 2022453,000$49.2M1.3%−18,712−4.0%ReducedHolders
Q1 2022471,712$55.8M1.3%−7,928−1.7%ReducedHolders
Q4 2021479,640$67.5M1.5%−4,140−0.9%ReducedHolders
Q3 2021483,780$57.1M1.4%−2,247−0.5%ReducedHolders
Q2 2021486,027$56.3M1.4%−2,742−0.6%ReducedHolders
Q1 2021488,769$58.6M1.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.